Accepted Manuscript Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective Diamantis I. Tsilimigras, Ioannis Ntanasis-Stathopoulos, Demetrios Moris, Eleftherios Spartalis, Timothy M. Pawlik PII: S0960-7404(18)30180-4 DOI: 10.1016/j.suronc.2018.07.015 Reference: SO 1124 To appear in: Surgical Oncology Received Date: 6 May 2018 Revised Date: 6 July 2018 Accepted Date: 29 July 2018 Please cite this article as: Tsilimigras DI, Ntanasis-Stathopoulos I, Moris D, Spartalis E, Pawlik TM, Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective, Surgical Oncology (2018), doi: 10.1016/j.suronc.2018.07.015. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.